AME
60
-2
PSX
40
3
AKAM
58
2
FAST
52
2
KMI
61
2
HPE
53
-2
MMC
70
2
COST
72
-2
IBM
78
3
HUM
35
6
XYL
49
-3
AMGN
59
12
PYPL
37
4
NEE
46
5
STX
59
-5
BDX
51
5
CME
36
5
THC
70
-2
UPS
46
5
ROK
48
-2
AME
60
-2
PSX
40
3
AKAM
58
2
FAST
52
2
KMI
61
2
HPE
53
-2
MMC
70
2
COST
72
-2
IBM
78
3
HUM
35
6
XYL
49
-3
AMGN
59
12
PYPL
37
4
NEE
46
5
STX
59
-5
BDX
51
5
CME
36
5
THC
70
-2
UPS
46
5
ROK
48
-2
Financhill
Back

Omnicell Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
41

OMCL
Omnicell

Last Price:
27.46
Seasonality Move:
12%
Sell
38

RARE
Ultragenyx Pharmaceutical

Last Price:
39.58
Seasonality Move:
3.65%
Sell
41
Omnicell (OMCL) is a Sell

Is Omnicell a Buy, Sell or Hold?

  • The current Omnicell [OMCL] share price is $28.26. The Score for OMCL is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • OMCL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
38
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $38.02. The Score for RARE is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

OMCL Stock Price Chart

What is Omnicell's stock price today?

  • The Omnicell share price today is $28.26
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and OMCL is experiencing buying pressure, which is a positive indicator for future bullish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $38.02
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing slight buying pressure.

OMCL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.64 Sell
Relative Strength Index (14 RSI): 41.67 Sell
Chaikin Money Flow: 299643 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (28.68 - 32.08) Sell
Bollinger Bands (100): (27.04 - 30.86) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.74 Sell
Relative Strength Index (14 RSI): 40.05 Sell
Chaikin Money Flow: 76134 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (39.06 - 42.34) Sell
Bollinger Bands (100): (41.13 - 48.85) Sell

OMCL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 28.31 Sell
20-day SMA: 30.25 Sell
50-day SMA: 29.36 Sell
200-day SMA: 34.11 Sell
8-day EMA: 28.44 Sell
20-day EMA: 29.37 Sell
50-day EMA: 29.59 Sell
200-day EMA: 36.48 Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.68 Sell
20-day SMA: 40.48 Sell
50-day SMA: 42.18 Sell
200-day SMA: 42.45 Sell
8-day EMA: 39.81 Sell
20-day EMA: 40.64 Sell
50-day EMA: 42.13 Sell
200-day EMA: 43.5 Sell

Omnicell Earnings Growth & OMCL Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.06 per share, a decrease this year of $0.61 per share, and an increase next year of $0.30 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

Omnicell Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):